Beijing Chunlizhengda reports strong profit growth in first half of 2025

For the six months ended June 30, 2025, Beijing Chunlizhengda Medical Instruments Co. reported revenue of 487,596,405.66 yuan, a 28.27% increase from 380,130,570.92 yuan in the same period last year. Net profit attributable to shareholders of the parent company rose by 44.85% to 114,469,490.87 yuan, up from 79,026,078.82 yuan in the prior year. Basic and diluted earnings per share were 0.30 yuan, an increase from 0.21 yuan.

The company's income tax expenses increased by 212.27% to 12,831,365.21 yuan, primarily due to the higher profit. Selling expenses decreased by 13.65% to 96,267,759.62 yuan, mainly attributable to a reduction in marketing expenses. Monetary funds saw a slight decrease from 1,139,778,517.24 yuan as of December 31, 2024 to 1,133,922,627.73 yuan as of June 30, 2025.

Total assets grew to 3,488,808,021.55 yuan from 3,465,734,982.98 yuan. The company actively expanded into international markets and implemented internal cost-reduction and efficiency-improvement measures, contributing to enhanced profitability.